MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 152 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $933,000 | +6.1% | 11,016 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $879,000 | -4.9% | 11,016 | +16.2% | 0.01% | -11.1% |
| Q2 2021 | $924,000 | -6.1% | 9,481 | +12.7% | 0.01% | -10.0% |
| Q1 2021 | $984,000 | -0.4% | 8,409 | -5.4% | 0.01% | 0.0% |
| Q4 2020 | $988,000 | +33.0% | 8,890 | +42.0% | 0.01% | +25.0% |
| Q3 2020 | $743,000 | +4.8% | 6,260 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $709,000 | +69.6% | 6,260 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $418,000 | -26.7% | 6,260 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $570,000 | +45.4% | 6,260 | +37.6% | 0.01% | +20.0% |
| Q3 2019 | $392,000 | +58.1% | 4,549 | +91.9% | 0.01% | +66.7% |
| Q2 2019 | $248,000 | -16.5% | 2,370 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $297,000 | +11.2% | 2,370 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $267,000 | -25.6% | 2,370 | +41.2% | 0.00% | 0.0% |
| Q3 2018 | $359,000 | – | 1,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |